Rachel Karry
- Biological Psychiatry top 1%
- Clinical Biochemistry top 1%
- Paraoxonase enzyme and polymorphisms 4
- Behavioral Neuroscience top 5%
- Developmental Neuroscience top 5%
- Neurogenesis and neuroplasticity mechanisms 4
-
- Neuroscience and Neuropharmacology Research 5
- Genetic Neurodegenerative Diseases 3
-
- Mitochondrial Function and Pathology 7
- Pluripotent Stem Cells Research 3
-
- Apelin-related biomedical research 4
-
- Growth Hormone and Insulin-like Growth Factors 3
- Co-authors
- Dorit Ben‐ShacharEhud KleinMichael AviramDorit Ben ShacharMira RosenblatElsa PavlotzkyDaniel AberdamIsabelle Petit
- Partner nations
- IsraelGermanyUnited States
In The Last Decade
Rachel Karry
32 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 106
- Biological Psychiatry 289
- Clinical Biochemistry 371
- Behavioral Neuroscience 136
- Developmental Neuroscience 99
- Cellular and Molecular Neuroscience 351
Countries citing papers authored by Rachel Karry
This map shows the geographic impact of Rachel Karry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Karry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Karry more than expected).
Fields of papers citing papers by Rachel Karry
This network shows the impact of papers produced by Rachel Karry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Karry. The network helps show where Rachel Karry may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel Karry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 23 | |
| 2 | 2016 | 19 | |
| 3 | 2013 | 8 | |
| 4 | 2011 | 8 | |
| 5 | 2010 | 15 | |
| 6 | 2009 | 15 | |
| 7 | 2008 | 38 | |
| 8 | 2008 | 15 | |
| 9 | 2008 | 174 | |
| 10 | 2007 | 32 | |
| 11 | 2007 | 70 | |
| 12 | 2007 | 7 | |
| 13 | 2005 | 90 | |
| 14 | 2005 | 73 | |
| 15 | 2004 | 170 | |
| 16 | 2004 | 45 | |
| 17 | 2004 | 50 | |
| 18 | 2004 | 56 | |
| 19 | 2003 | 19 | |
| 20 | 2002 | 121 |
About Rachel Karry
Rachel Karry is a scholar working on Developmental Neuroscience, Clinical Biochemistry and Biological Psychiatry, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (7 papers), Neuroscience and Neuropharmacology Research (5 papers), Apelin-related biomedical research (4 papers), Paraoxonase enzyme and polymorphisms (4 papers), Neurogenesis and neuroplasticity mechanisms (4 papers), Genetic Neurodegenerative Diseases (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Pluripotent Stem Cells Research (3 papers). The work is most often cited by research in Biological Psychiatry (289 citations), Clinical Biochemistry (371 citations) and Behavioral Neuroscience (136 citations). Rachel Karry has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include Dorit Ben‐Shachar, Ehud Klein, Michael Aviram, Dorit Ben Shachar, Mira Rosenblat, Elsa Pavlotzky, Daniel Aberdam, Isabelle Petit, Frank Müller and Ettie Grauer. Their work appears in journals such as PLoS ONE, Circulation Research and Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.